tiprankstipranks
Trending News
More News >
EQL Pharma AB (DE:7JK)
FRANKFURT:7JK
Germany Market

EQL Pharma AB (7JK) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
EQL Pharma AB’s (7JK) Moving Averages Convergence Divergence (MACD) indicator is 0.10, suggesting EQL Pharma AB is a Buy.
EQL Pharma AB’s (7JK) 20-Day exponential moving average is 7.61, while EQL Pharma AB’s (7JK) share price is €8.07, making it a Buy.
EQL Pharma AB’s (7JK) 50-Day exponential moving average is 7.39, while EQL Pharma AB’s (7JK) share price is €8.07, making it a Buy.

EQL Pharma AB (7JK) Pivot Points

Jun 18, 2025, 09:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.64
7.70
7.80
7.86
7.96
8.02
8.12
Fibonacci
7.70
7.76
7.80
7.86
7.92
7.96
8.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

EQL Pharma AB (7JK) Moving Averages

Jun 18, 2025, 09:13 AM
Period
Simple
Exponential
MA5
7.75Sell
7.71Sell
MA10
7.61Buy
7.67Buy
MA20
7.67Buy
7.61Buy
MA50
7.25Buy
7.39Buy
MA100
7.14Buy
7.09Buy
MA200
6.46Buy
6.40Buy
EQL Pharma AB’s (7JK) 10-Day exponential moving average is 7.67, while EQL Pharma AB’s (7JK) share price is €8.07, making it a Buy.
EQL Pharma AB’s (7JK) 100-Day exponential moving average is 7.09, while EQL Pharma AB’s (7JK) share price is €8.07, making it a Buy.
EQL Pharma AB’s (7JK) stock price is €8.07 and EQL Pharma AB’s (7JK) 50-day simple moving average is 7.25, creating a Buy signal.
EQL Pharma AB’s (7JK) stock price is €8.07 and EQL Pharma AB’s (7JK) 100-day simple moving average is 7.14, creating a Buy signal.
EQL Pharma AB’s (7JK) stock price is €8.07 and EQL Pharma AB’s (7JK) 200-day simple moving average is 6.46, creating a Buy signal.

EQL Pharma AB (7JK) Technical Indicators

Jun 18, 2025, 09:13 AM
Name
Value
Implied Action
RSI (14)
53.41
Neutral
STOCH (9,6)
74.54
Neutral
STOCHRSI (14)
64.62
Neutral
MACD (12,26)
0.10
Buy
ADX (14)
17.03
Buy
Williams %R
-41.07
Buy
CCI (14)
36.10
Neutral
ATR (14)
0.19
-
Ultimate Oscillator
47.95
Neutral
ROC
-0.90
Sell
EQL Pharma AB’s (7JK) Relative Strength Index (RSI) is 53.41, creating a Neutral signal.
EQL Pharma AB’s (7JK) Trend Strength Indicator (ADX) is 17.03, creating a Buy signal.
EQL Pharma AB’s (7JK) Commodity Channel Index (CCI) is 36.10, creating a Neutral signal.
EQL Pharma AB’s (7JK) Price Rate of Change (ROC) is -0.90, creating a Sell signal.

FAQ

Is 7JK a Buy, Hold, or Sell?
Based on 7JK’s technical indicators, 7JK is a Buy.
    What is 7JK’s RSI (14)?
    7JK’s RSI (14) is 53.41, which suggests 7JK is a Neutral.
      What is 7JK’s MACD?
      7JK’s MACD is 0.10, which suggests 7JK is a Buy.
        What is 7JK’s 5-day moving average?
        7JK’s 5-day moving average is 7.75, which suggests 7JK is a Sell.
          What is 7JK’s 20-day moving average?
          7JK 20-day moving average is 7.67, which suggests 7JK is a Buy.
            What is 7JK’s 50-day moving average?
            7JK’s 50-day moving average is 7.25, which suggests 7JK is a Buy.
              What is 7JK’s 200-day moving average?
              7JK’s 200-day moving average is 6.46, which suggests 7JK is a Buy.
                What is 7JK’s Williams % R (14)?
                7JK’s Williams % R (14) is -41.07, which suggests 7JK is a Buy.
                  What is 7JK’s CCI (14)?
                  7JK’s CCI (14) is 36.10, which suggests 7JK is a Neutral.
                    What is the share price of EQL Pharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis